Search

Your search keyword '"Perlin, David S."' showing total 1,033 results

Search Constraints

Start Over You searched for: Author "Perlin, David S." Remove constraint Author: "Perlin, David S."
1,033 results on '"Perlin, David S."'

Search Results

1. Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap

3. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

5. Fungicide-tolerant persister formation during cryptococcal pulmonary infection

6. Pervasive but Neglected: A Perspective on COVID-19-Associated Pulmonary Mold Infections Among Mechanically Ventilated COVID-19 Patients

9. Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium.

10. COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions?

11. COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment

15. An aptamer-biosensor for azole class antifungal drugs

16. Evolutionary dynamics in gut-colonizing Candida glabrata during caspofungin therapy: Emergence of clinically important mutations in sphingolipid biosynthesis.

23. Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine Mimic

24. Humoral and cellular immune responses against SARS-CoV-2 post-vaccination in immunocompetent and immunocompromised cancer populations

26. Cell Wall-Modifying Antifungal Drugs

29. A Preclinical Candidate Targeting Mycobacterium tuberculosis KasA

32. Overlooked Candida glabrata petites are echinocandin tolerant, induce host inflammatory responses, and display poor in vivo fitness

34. Molecular and Clinical Epidemiology of SARS-CoV-2 Infection among Vaccinated and Unvaccinated Individuals in a Large Healthcare Organization from New Jersey

36. Pharmacokinetics of Posaconazole Within Epithelial Cells and Fungi: Insights Into Potential Mechanisms of Action During Treatment and Prophylaxis

37. Randomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndrome

40. Echinocandin Resistance

44. OverlookedCandida glabratapetites are echinocandin tolerant, induce host inflammatory responses, and display poorin vivofitness

47. Candida parapsilosis isolates carrying mutations outside of FKS1 hotspot regions confer high echinocandin tolerance and facilitate the development of echinocandin resistance

48. Inherited and acquired errors of type I interferon immunity govern susceptibility to COVID-19 and multisystem inflammatory syndrome in children

Catalog

Books, media, physical & digital resources